ANTIMALARIAL ACTIVITY OF OROTIC ACID ANALOGS
乳清酸类似物的抗疟活性
基本信息
- 批准号:3454871
- 负责人:
- 金额:$ 7.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-08-01 至 1994-07-31
- 项目状态:已结题
- 来源:
- 关键词:DNA Plasmodium falciparum RNA antimalarial agents antimetabolites autoradiography drug design /synthesis /production drug interactions drug metabolism drug screening /evaluation enzyme inhibitors enzyme mechanism erythrocytes gel electrophoresis high performance liquid chromatography intracellular parasitism malaria nucleotide analog parasitic disease chemotherapy pharmacokinetics radionuclides scintillation spectrometry thymidylate synthase ultraviolet spectrometry
项目摘要
In recent decades Plasmodium falciparum has re-emerged as the major health
threat in most tropical regions of the world. We have recently
demonstrated, in vitro, that 5-fluoroorotate is exceedingly toxic to P.
falciparum (IC30=6x10-9M). In contrast, 5-fluoroorotate is much less toxic
to human fibrosarcoma cells (IC30=5x10-5M). Furthermore, the combination of
uridine and 5-fluoroorotate says mammalian cells from toxicity without
compromising the antimalarial activity of 5-fluoroorotate. Finally, 5-
fluoroorotate is very effective against multiple drug-resistant parasites.
The primary goal of the proposed research is to determine the molecular
basis for the selective antimalarial activity of 5-fluoroorotate. We will
characterize the transport of 5-fluoroorotate into erythrocytes infected
with asynchronous as well as synchronous populations of P. falciparum. We
will also follow the metabolism of radioactive drug into nucleotides and
into macromolecules such as RNA, and the enzyme thymidylate synthetase.
Experiments will be performed to determine whether inactivation of malarial
thymidylate synthetase plays a role in whether inactivation of malarial
thymidylate synthetase plays a role in whether inactivation of malarial
thymidylate synthetase plays a role in 5-fluoroorotate toxicity. Kinetic
interactions between parasite 5-fluoro 2' -deoxyuridylate will be analyzed.
A new antimetabolite, trans 5-fluorodihydrocrotate will be synthesized and
tested as a selective antimalarial drug. If successful in vitro, it will
tell us that derivatives of dihydroorotate may also be highly effective
antimalarial drugs.
近几十年来,恶性疟原虫重新成为主要的健康来源。
世界上大多数热带地区的威胁。我们最近做了
体外实验表明,5-氟代甲酸对P.
恶性(IC_(30)=6×10~(-9)M)。相比之下,5-氟甲酸酯的毒性要小得多。
对人纤维肉瘤细胞(IC30=5×10~(-5)M)。此外,两种技术的结合
尿苷和5-氟代甲酸表示,哺乳动物细胞在没有
降低5-氟代苦参碱的抗疟疾活性。最后,5-
氟甲酸酯对多种耐药寄生虫非常有效。
这项拟议研究的主要目标是确定分子
5-氟罗特酸盐选择性抗疟疾活性的基础。我们会
5-氟代苦参碱在感染红细胞中的转运特征
与恶性疟原虫的异步群和同步群在一起。我们
也会跟随放射性药物代谢成核苷酸和
转化为大分子,如核糖核酸和胸苷合成酶。
将进行实验以确定疟疾灭活是否
胸苷合成酶在疟疾灭活中的作用
胸苷合成酶在疟疾灭活中的作用
胸苷合成酶在5-氟代核苷毒性中起作用。动能
将分析寄生虫5-氟-2‘-脱氧尿苷之间的相互作用。
将合成一种新的抗代谢药物--反式5-氟二氢巴豆酸酯,并
作为一种选择性抗疟疾药物进行测试。如果在体外成功,它将
告诉我们二氢罗丹明的衍生物也可能是非常有效的
抗疟疾药物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PRADIPSINH K. RATHOD其他文献
PRADIPSINH K. RATHOD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PRADIPSINH K. RATHOD', 18)}}的其他基金
High Throughput Screens for Malaria Topoisomerases
疟疾拓扑异构酶的高通量筛选
- 批准号:
8217269 - 财政年份:2011
- 资助金额:
$ 7.84万 - 项目类别:
相似海外基金
Genomics and sero-epidemiology of Plasmodium falciparum malaria in a pre-elimination setting
消灭前环境中恶性疟原虫疟疾的基因组学和血清流行病学
- 批准号:
10666280 - 财政年份:2023
- 资助金额:
$ 7.84万 - 项目类别:
Elucidating mechanisms for artemisinin-induced dormancy in Plasmodium falciparum
阐明青蒿素诱导恶性疟原虫休眠的机制
- 批准号:
10742385 - 财政年份:2023
- 资助金额:
$ 7.84万 - 项目类别:
Investigating the role of SCF ubiquitin ligases during sexual development of Plasmodium falciparum
研究 SCF 泛素连接酶在恶性疟原虫性发育过程中的作用
- 批准号:
MR/W025566/1 - 财政年份:2023
- 资助金额:
$ 7.84万 - 项目类别:
Research Grant
Rotation 1: Investigating the role(s) of the putative FANCJ helicase in the malaria parasite Plasmodium falciparum
第 1 轮:研究假定的 FANCJ 解旋酶在疟原虫恶性疟原虫中的作用
- 批准号:
2886902 - 财政年份:2023
- 资助金额:
$ 7.84万 - 项目类别:
Studentship
Exploring the role of phosphoinositides in the trafficking of proteins to the apical complex in the malaria parasite Plasmodium falciparum.
探索磷酸肌醇在疟原虫恶性疟原虫顶复合体蛋白质运输中的作用。
- 批准号:
495093 - 财政年份:2023
- 资助金额:
$ 7.84万 - 项目类别:
Operating Grants
DDT-BMQ-0000100 Qualification of the Plasmodium falciparum 18S rRNA biomarker for malaria-endemic controlled human malaria infection studies
DDT-BMQ-0000100 疟疾流行控制人类疟疾感染研究中恶性疟原虫 18S rRNA 生物标志物的鉴定
- 批准号:
10836140 - 财政年份:2023
- 资助金额:
$ 7.84万 - 项目类别:
Defining molecular determinants of Plasmodium falciparum hematopoietic infection using single cell profiling and genetics
使用单细胞分析和遗传学定义恶性疟原虫造血系统感染的分子决定因素
- 批准号:
EP/Y003705/1 - 财政年份:2023
- 资助金额:
$ 7.84万 - 项目类别:
Fellowship
Detailed mechanism of trafficking proteins involved in the virulence of Plasmodium falciparum
恶性疟原虫毒力中涉及的运输蛋白的详细机制
- 批准号:
22KF0032 - 财政年份:2023
- 资助金额:
$ 7.84万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Étude du rôle de la phosphatase de phosphoinositides SAC1 dans le trafic de protéines au complexe apical chez le parasite de la malaria Plasmodium falciparum
疟疾疟原虫顶端寄生虫复合物中磷酸肌醇磷酸酶 SAC1 的研究
- 批准号:
486094 - 财政年份:2022
- 资助金额:
$ 7.84万 - 项目类别:
Studentship Programs
Developing a multi-component vaccine harnessing potent antibody and cellular responses against the blood-stage of Plasmodium falciparum
开发一种多成分疫苗,利用针对恶性疟原虫血液阶段的有效抗体和细胞反应
- 批准号:
10614511 - 财政年份:2022
- 资助金额:
$ 7.84万 - 项目类别: